Related Experiment Video
Updated: Aug 29, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities
Bertil B Fredholm1, Per Svenningsson
1Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. Bertil.Fredholm@fyfa.ki.se
Abstract:
This brief review presents a personal perspective on the historical development of the current knowledge about the biologically important concept of functional antagonism between adenosine A2A and dopamine D2 receptors in caudate-putamen, accumbens, and tuberculum olfactorium. In the 1970s, studies of dopamine actions suggested an unexpected role of adenosine. Developments during the next decade substantiated this finding and demonstrated that a subform of adenosine A2 receptors was enriched in the basal ganglia. Cloning of adenosine receptors provided better tools for cellular localization and showed that A2A receptors are closely associated with D2 receptors. Distinct functional interactions at several levels were discovered, and there is now strong evidence that A2A receptors are tonically active and modified by dopamine acting at D2 receptors. Development of selective antagonists and knockout mice have highlighted the potential usefulness of A2A antagonists in decreasing symptoms and progression of Parkinson's disease-something that has also been vindicated by careful epidemiologic studies. There are issues of efficacy and potential side effects that need to be resolved, but the future looks bright.
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
